Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,500,755 papers from all fields of science
Search
Sign In
Create Free Account
IFL Regimen
Known as:
IFL-Modified Saltz Regimen
, IFL-Saltz Regimen
, Irinotecan-Fluorouracil-Leucovorin Regimen
A regimen consisting of irinotecan, fluorouracil and leucovorin, all administered as bolus doses, and used for the treatment of advanced stage…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Colorectal Carcinoma
Fluorouracil
IFL protocol
Irinotecan hydrochloride
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
103 - Featured Poster SessionSentinel lymph nodes in vulvar cancer: Management dilemmas in patients with positive nodes and larger tumors
A. Nica
,
M. Cesari
,
+4 authors
L. Gien
2017
Corpus ID: 80555064
2017
2017
Perbaikan Antarmuka Dan Pengembangan Fitur Baru Situs Web Indonesian Future Leaders Chapter Malang Menggunakan Framework Affordance-Based Design
Nissa Madaniyah Fadhilah
2017
Corpus ID: 194642194
IFL Malang merupakan organisasi yang bergerak di bidang pendidikan, sosial dan mewadahi komunitas untuk bersinergi bersama…
Expand
2016
2016
ANALISIS LINGKUNGAN SEBAGAI DASAR PERUMUSAN STRATEGI PADA ORGANISASI NONPROFIT (STUDI KASUS PADA INDONESIAN FUTURE LEADERS CHAPTER MALANG)
A. Holy
2016
Corpus ID: 191572011
Penelitian ini bertujuan untuk menentukan strategi yang tepat dan sesuai dengan hasil analisis lingkungan pada suatu organisasi…
Expand
2009
2009
Phase II study of bevacizumab (B), camptosar (I), high-dose 24-hour continuous intravenous infusion of floxuridine (F) and leucovorin (L) in patients with previously untreated metastatic colon cancer…
B. Ardalan
,
M. Feagans
,
+8 authors
A. Livingstone
Journal of Clinical Oncology
2009
Corpus ID: 2899434
e15114 Background: In a previous study, IFL was used in patients (pt) with untreated metastatic colon cancer and a median overall…
Expand
2006
2006
Efficacy and safety of bevacizumab in combination with irinotecan and infusional 5-FU as first-line treatment for patients with metastatic colorectal cancer.
A. Sobrero
,
S. Ackland
,
+6 authors
S. Young
Journal of Clinical Oncology
2006
Corpus ID: 24399122
3544 Background: Bevacizumab is a monoclonal antibody that, by inhibiting VEGF, inhibits tumour angiogenesis. It has been proven…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required